Company Filing History:
Years Active: 2010-2012
Title: **Andrey Glushkov: Innovator in Lipid Regulation**
Introduction
Andrey Glushkov, based in Moscow, Russia, is a notable inventor with a focus on the development of innovative compounds aimed at regulating lipid levels in the human body. With a portfolio of three patents, he has significantly contributed to the field of medicinal chemistry, particularly in the context of treating diseases related to stearoyl-CoA desaturase enzymes.
Latest Patents
Glushkov's latest patents include:
1. **3, 4-dihydroquinoxalin-2(1H)-ones for use as stearoyl CoA desaturase inhibitors**. This invention presents a range of compounds valuable in the treatment and prevention of various diseases associated with abnormal lipid levels, such as cardiovascular issues, diabetes, and obesity.
2. **Pyrido[2,3-B] pyrazin-3(4H)-ones for use as stearoyl CoA desaturase inhibitors**. Similar to his previous work, this patent focuses on inhibitors of stearoyl-CoA desaturase, aiming to address various human diseases, particularly those linked to metabolic syndrome and oily skin conditions.
Career Highlights
Andrey has built an impressive career, including notable tenures at Gilead Palo Alto, Inc. and Gilead Sciences, Inc. His work has consistently revolved around the synthesis of compounds that target lipid metabolism, demonstrating his commitment to addressing significant health challenges through scientific innovation.
Collaborations
Throughout his career, Glushkov has collaborated with other distinguished professionals in the field, including Dmitry Koltun and Jeff A Zablocki. These partnerships have enhanced his research and development efforts, leading to the successful patenting of his innovative compounds.
Conclusion
Andrey Glushkov stands out as a forward-thinking inventor, whose contributions to lipid regulation reflect his deep understanding of biochemistry and medicine. His work holds promise for improving the health outcomes of individuals affected by metabolic disorders, and his patents represent significant advancements in the development of therapeutic agents.